Tag: European Commission

Inviting views on how a stronger EU disability strategy up to 2030 can support inclusive research, data sharing and innovation.
Gathering key stakeholders, including EU policymakers, industry leaders, patient advocacy groups, researchers, and healthcare providers. Its goal is to identify concrete actions and incentives to enhance innovation across the rare disease ecosystem.
Sharing patient‑centred methods, early diagnostics, and data‑driven trial innovation to accelerate rare disease research across Europe.
Taking place on 10 April 2025 at the Medical University of Warsaw, Poland